- Instructions for Authors
- Aims and Scope
- General Information
- Types of Papers Published
- Manuscript Submission
- Editorial Procedure
- Page Limits and Page Charges
- Editorial Office
- Manuscript Preparation
- Arrangement of the Manuscript
- Text Formatting
- Electronic Supplementary Material
- Ethical Responsibilities of Authors
- Authorship principles
- Compliance with Ethical Standards
- Conflicts of Interest / Competing Interests
- Open Choice
- After Acceptance
- Online First
- Open access publishing
Instructions for Authors
Aims and Scope
The "Journal of General Plant Pathology" welcomes all manuscripts that advance understanding of plant diseases or their control, including pathogen characterization, identification of pathogens, disease physiology and biochemistry, molecular biology, morphology and ultrastructure, genetics, disease transmission, ecology and epidemiology, chemical and biological control, disease assessment, and other topics relevant to plant pathological disorders. Novelty and originality of research are the criteria for manuscripts published in Journal of General Plant Pathology.
All articles submitted to the journal must comply with the Instructions for Authors. Failure to do so will result in the rejection of the manuscript before peer review.
Types of Papers Published
Contributions should fit one of the following categories: (i) Full-length articles, (ii) Short communications, (iii) Disease notes, (iv) Techniques, (v) Letters to the editor, and (vi) Reviews. Full-length articles and short communications: These should be original research reports that have not been submitted elsewhere. Disease notes: Authors should describe symptoms, the hosts, when and where the disease occurred, and pathogen identification (or proof of pathogenicity). They should also state the significance of the disease. Techniques: JGPP accepts only reports of techniques that are unique and useful in the plant pathology field. Letters to the editor: A letter to the editor is a comment on research published in the journal or elsewhere. Reviews: Reviews should be discussed with the Editor-in-Chief prior to submission.
- Legal Requirements
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities - tacitly or explicitly - at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
- How to Submit
Manuscripts should be written in English. If the manuscript conforms to the guidelines specified in the instructions, the date received will be the date the manuscript was received at the editorial office. Authors should submit their manuscripts to the Journal of General Plant Pathology online. Electronic submission substantially reduces the editorial processing and reviewing times and shortens overall publication times. Please connect directly to the site and upload all of your manuscript files following the instructions given on the screen. In case you have any difficulty while submitting your manuscript online, click on HELP in the upper left corner.
Please view your Reference Checking Results during electronic submission and attempt to resolve any problems with your references prior to submitting your manuscript.
The Editorial Committee reserves the right to accept or reject the manuscript for publication. The Committee may advise the author to revise the manuscript according to suggestions by reviewers. A manuscript written in poor English may not be accepted regardless of its content. When revision of a manuscript has been requested, the revised manuscript should be submitted by the due date. Otherwise, the manuscript will be processed as one withdrawn from submission. The accepted date will be the day when the Editor-in-Chief has judged it to be publishable after the completion of the reviewing process.
New nucleotide data must be deposited in the DDBJ/EMBL/GenBank databases and an accession number obtained before a paper can be accepted for publication. Submission to any one of the three collaborating databanks is sufficient to ensure data entry in all. The accession number should appear as a footnote on the title page: The nucleotide sequence data reported are available in the DDBJ/EMBL/GenBank databases under the accession number(s) ----. The accession number should also be included in the text, tables, or figure legends, as appropriate.
Please indicate the source of microbiological cultures. Authors are encouraged to deposit cultures at recognized institutions and cite the place of deposit in the text.
Page Limits and Page Charges
Reviews and Full-length articles should not exceed 8 and 6 printed pages, respectively, and Short communications, Letters to the editor, and Disease notes should be no longer than 3 printed pages. Techniques should not exceed 4 pages. Pages beyond these limitations will be subject to an excess page charge. Reviews and Full-length articles cannot exceed 12 and 10 printed pages, respectively, and Short communications or Letters to the editor, 5 printed pages. Disease notes cannot exceed 3 printed pages. One printed page contains about 900 words.
For a corresponding author who is a member of the Phytopathological Society of Japan (PSJ), there is no page charge. For a nonmember corresponding author, the page charge is US$15 per printed page. The excess page charge is US$75 per 1/2 page for members and nonmembers alike. Color art is free of charge for online publications. For the print version, the charge for color art is EUR 950 plus 19% VAT for each publication.
This statement of page charges notwithstanding, a Japanese corresponding author will be charged at a different standard and should pay in yen as specified in the general requirements in the Japanese Journal of Phytopathology (no charge and JPY 6000 per printed page for members and nonmembers, respectively; JPY 18 000 per 1/2 excess page for members and nonmembers alike.)
Because of fluctuation in printing costs, page charges are subject to change without notice.
Editor-in-Chief of the Journal of General Plant Pathology
Prof. Dr. Yuki ICHINOSE
Graduate School of Environment and Science, Okayama University
Tsushima, Okayama 700-8530, Japan
Manuscripts should be formatted with 3-cm margins, 25 lines per page on either A4 (21.0 × 29.7 cm) or 8½ × 11-inch page. All pages, including tables, figures, and legends, should include the author's name and the page number at the top right corner for identification. Line numbers should also be included in the left margin of all papers. Italic and boldface type should be specified using the features of standard word-processing software.
Arrangement of the Manuscript
Pages should be numbered consecutively and arranged in the following order.
Page 1: Title Page
The title page should include:
- A concise and informative title
- The name(s) of the author(s)
- The affiliation(s) and address(es) of the author(s)
- The e-mail address, telephone and fax numbers of the corresponding author
- Total text pages
- The numbers of tables and figures
Page 2: Abstract and Keywords
Please provide an abstract of no more than 250 words for Reviews and Full-length articles, 100 words for Short communications, Letters to the editor, Disease notes and Techniques. The abstract should not contain any undefined abbreviations or unspecified references.
Please provide a maximum of six keywords which can be used for indexing purposes, including the name of organisms (common name or scientific name), method or other words or phrases that represent the subject of the study, such as fungistasis, Fusarium oxysporum, phytoalexins, late blight, Solanum tuberosum.
Page 3: Text
Please provide a text, divided into the following sections: Introduction, Materials and methods, Results, Discussion, Acknowledgements, References, and figure legends. Authors should consult recent issues for details of style and presentation. A short communication, letter to the editor, or disease note should not be divided into sections, except for References. Mathematical equations should be written in a form such as (RT/nF)•ln(b/a).
For submission in Word
- Use a normal, plain font (e.g., 12-point Times Roman) for text.
- Use the automatic page numbering function to number the pages.
- Do not use field functions.
- Use tab stops or other commands for indents, not the space bar.
- Use the table function, not spreadsheets, to make tables.
- Use the equation editor or MathType for equations.
- Save your file in docx format (Word 2007 or higher) or doc format (older Word versions).
Please use no more than three levels of displayed headings.
Abbreviations and acronyms
Abbreviations should be defined at first mention and used consistently thereafter.
Units of Measurement
Length: km, m, mm, µm, nm, etc.
Area: km2, m2, cm2, etc. a, ha are acceptable.
Capacity: kl, l (liters in the text), ml, µl, etc. Do not use lambda and italic l.
Volume: km3, m3, cm3 (not cc), mm3, etc.
Mass: kg, g, mg, µg (not gamma), ng, pg, etc.
Time: s, min, h, day(s), week(s), month(s), year(s)
Concentration: M, mM, N, % (only after number and in tables and figures), g/l, mg/l, µg/l,
Molecular weight: mol wt
Others: Radioisotopes: 32P
Radiation dose: Bq
Oxidation-reduction potential: rH
Hydrogen ion concentration: pH
Genus and species names should be in italics. The common names of plants should not be capitalized.
Please use the standard mathematical notation for formulae, symbols etc.:
- Italic for single letters that denote mathematical constants, variables, and unknown quantities
- Roman/upright for numerals, operators, and punctuation, and commonly defined functions or abbreviations, e.g., cos, det, e or exp, lim, log, max, min, sin, tan, d (for derivative)
Bold for vectors, tensors, and matrices.
Footnotes on the title page are not given reference symbols. Footnotes to the text are numbered consecutively.
Acknowledgements of people, grants, funds, etc. should be placed in a separate section before the reference list. The names of funding organizations should be written in full.
The list of References should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text. Do not use footnotes or endnotes as a substitute for a reference list.
Citation in Text
Cite references in the text by name and year in parentheses. Some examples:
- Negotiation research spans many disciplines (Thompson 1990).
- This result was later contradicted (Becker and Seligman 1996).
- This effect has been widely studied (Abbott 1991; Barakat et al. 1995; Kelso and Smith 1998; Medvec et al. 1993).
The reference list at the end of the paper should include only works cited in the text and should be arranged alphabetically by the last names of the first author of each work. References should be cited as follows: journal papers - names and initials of all authors, year in parentheses, full title, journal as abbreviated in accordance with international practice, volume number, first and last page numbers; books - names and initials of all authors, year, chapter title, names and initials of all editors, full title, edition, publisher, place of publication.
- Journal Article
Virtudazo EV, Nakamura H, Kakishima M (2001) Phylogenetic analysis of sugarcane rusts based on sequences of ITS, 5.8 S rDNA and D1/D2 regions of LSU rDNA. J Gen Plant Pathol 67:28–36
Kempken F (ed) (2002) The mycota XI. Agricultural applications. Springer, Berlin
- Book Chapter
Waterhouse PM, Upadhyaya NM (1999) Genetic engineering of virus resistance. In: Shimamoto K (ed) Molecular biology of rice. Springer, Berlin, pp 257–281
- Article by DOI
Kirschner R, Braun U, Chen Z-C, Oberwinkler F (2002) Pleurovularia, a new genus of hyphomycetes proposed for a parasite on leaves of Microstegium sp. (Poaceae). Mycoscience 43:15–20. doi: 10.1007/s102670200003
Escuadra GME, Amemiya Y (2008) Suppression of Fusarium wilt of spinach with compost amendments. J Gen Plant Pathol. doi: 10.1007/s10327-008-0090-8
- Online Document
Doe J (1999) Title of subordinate document. In: The dictionary of substances and their effects. Royal Society of Chemistry. Available via DIALOG. http://www.rsc.org/dose/title of subordinate document. Cited 15 Jan 1999
Always use the standard abbreviation of a journal's name according to the ISSN List of Title Word Abbreviations. If you are unsure, please use the full journal title.
Responsibility for the accuracy of bibliographic data rests entirely with the author.
- All tables are to be numbered using Arabic numerals.
- Tables should always be cited in text in consecutive numerical order.
- For each table, please supply a table title. The table title should explain clearly and concisely the components of the table.
- Identify any previously published material by giving the original source in the form of a reference at the end of the table title.
- Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and included beneath the table body.
- A unit of measure should be reported as the actual quantity multiplied by a power of 10 to give the reported quantity (the unit may be changed by the use of m or µ).
- Figures should match the size of either the column width (8.4 cm) or the printing area (17.4 × 23.4 cm).
- All figures are to be numbered using Arabic numerals.
- Figure parts should be denoted by lowercase letters (a, b, c). If illustrations are supplied with uppercase labeling, lowercase letters will still be used in the figure legends and citations.
- Figures should always be cited in text in consecutive numerical order.
- For each figure, please supply a figure legend.
- Make sure to identify all elements found in the figure in the legend.
- Identify any previously published material by giving the original source in the form of a reference at the end of the legend.
- The publisher reserves the right to reduce or enlarge figures.
- Figure legends should be grouped together in text.
Electronic Supplementary Material
Electronic supplementary material (ESM) for an article in the journal will be published on SpringerLink provided the material is submitted to the editors in electronic form together with the paper and is subject to peer review, and is accepted by the journal editors.
ESM may consist of
- information that cannot be printed: animations, video clips, sound recordings
- information that is more convenient in electronic form: sequences, spectral data, etc.
- large original data that relate to the paper, e.g. additional tables, illustrations, etc.
- If supplying any ESM, the text must make specific mention of the material as a citation, similar to that of figures and tables (e.g., ". . . as shown in Animation 3.").
After acceptance by the journal editors ESM will be published as received from the author in the online version only.
Ethical Responsibilities of Authors
This journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics (COPE) the journal will follow the COPE guidelines on how to deal with potential acts of misconduct.
Authors should refrain from misrepresenting research results which could damage the trust in the journal, the professionalism of scientific authorship, and ultimately the entire scientific endeavour. Maintaining integrity of the research and its presentation is helped by following the rules of good scientific practice, which include*:
- The manuscript should not be submitted to more than one journal for simultaneous consideration.
- The submitted work should be original and should not have been published elsewhere in any form or language (partially or in full), unless the new work concerns an expansion of previous work. (Please provide transparency on the re-use of material to avoid the concerns about text-recycling (‘self-plagiarism’).
- A single study should not be split up into several parts to increase the quantity of submissions and submitted to various journals or to one journal over time (i.e. ‘salami-slicing/publishing’).
- Concurrent or secondary publication is sometimes justifiable, provided certain conditions are met. Examples include: translations or a manuscript that is intended for a different group of readers.
- Results should be presented clearly, honestly, and without fabrication, falsification or inappropriate data manipulation (including image based manipulation). Authors should adhere to discipline-specific rules for acquiring, selecting and processing data.
- No data, text, or theories by others are presented as if they were the author’s own (‘plagiarism’). Proper acknowledgements to other works must be given (this includes material that is closely copied (near verbatim), summarized and/or paraphrased), quotation marks (to indicate words taken from another source) are used for verbatim copying of material, and permissions secured for material that is copyrighted.
Important note: the journal may use software to screen for plagiarism.
- Authors should make sure they have permissions for the use of software, questionnaires/(web) surveys and scales in their studies (if appropriate).
- Research articles and non-research articles (e.g. Opinion, Review, and Commentary articles) must cite appropriate and relevant literature in support of the claims made. Excessive and inappropriate self-citation or coordinated efforts among several authors to collectively self-cite is strongly discouraged.
- Authors should avoid untrue statements about an entity (who can be an individual person or a company) or descriptions of their behavior or actions that could potentially be seen as personal attacks or allegations about that person.
- Research that may be misapplied to pose a threat to public health or national security should be clearly identified in the manuscript (e.g. dual use of research). Examples include creation of harmful consequences of biological agents or toxins, disruption of immunity of vaccines, unusual hazards in the use of chemicals, weaponization of research/technology (amongst others).
- Authors are strongly advised to ensure the author group, the Corresponding Author, and the order of authors are all correct at submission. Adding and/or deleting authors during the revision stages is generally not permitted, but in some cases may be warranted. Reasons for changes in authorship should be explained in detail. Please note that changes to authorship cannot be made after acceptance of a manuscript.
*All of the above are guidelines and authors need to make sure to respect third parties rights such as copyright and/or moral rights.
Upon request authors should be prepared to send relevant documentation or data in order to verify the validity of the results presented. This could be in the form of raw data, samples, records, etc. Sensitive information in the form of confidential or proprietary data is excluded.
If there is suspicion of misbehavior or alleged fraud the Journal and/or Publisher will carry out an investigation following COPE guidelines. If, after investigation, there are valid concerns, the author(s) concerned will be contacted under their given e-mail address and given an opportunity to address the issue. Depending on the situation, this may result in the Journal’s and/or Publisher’s implementation of the following measures, including, but not limited to:
- If the manuscript is still under consideration, it may be rejected and returned to the author.
- If the article has already been published online, depending on the nature and severity of the infraction:
- an erratum/correction may be placed with the article
- an expression of concern may be placed with the article
- or in severe cases retraction of the article may occur.
The reason will be given in the published erratum/correction, expression of concern or retraction note. Please note that retraction means that the article is maintained on the platform, watermarked “retracted” and the explanation for the retraction is provided in a note linked to the watermarked article.
- The author’s institution may be informed
- A notice of suspected transgression of ethical standards in the peer review system may be included as part of the author’s and article’s bibliographic record.
Authors have an obligation to correct mistakes once they discover a significant error or inaccuracy in their published article. The author(s) is/are requested to contact the journal and explain in what sense the error is impacting the article. A decision on how to correct the literature will depend on the nature of the error. This may be a correction or retraction. The retraction note should provide transparency which parts of the article are impacted by the error.
Suggesting / excluding reviewers
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts. When suggesting reviewers, authors should make sure they are totally independent and not connected to the work in any way. It is strongly recommended to suggest a mix of reviewers from different countries and different institutions. When suggesting reviewers, the Corresponding Author must provide an institutional email address for each suggested reviewer, or, if this is not possible to include other means of verifying the identity such as a link to a personal homepage, a link to the publication record or a researcher or author ID in the submission letter. Please note that the Journal may not use the suggestions, but suggestions are appreciated and may help facilitate the peer review process.
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to.
The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before the work is submitted.
The Publisher does not prescribe the kinds of contributions that warrant authorship. It is recommended that authors adhere to the guidelines for authorship that are applicable in their specific research field. In absence of specific guidelines it is recommended to adhere to the following guidelines*:
All authors whose names appear on the submission
1) made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work;
2) drafted the work or revised it critically for important intellectual content;
3) approved the version to be published; and
4) agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
* Based on/adapted from:
Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate).
The decision whether such information should be included is not only dependent on the scope of the journal, but also the scope of the article. Work submitted for publication may have implications for public health or general welfare and in those cases it is the responsibility of all authors to include the appropriate disclosures and declarations.
All authors are requested to make sure that all data and materials as well as software application or custom code support their published claims and comply with field standards. Please note that journals may have individual policies on (sharing) research data in concordance with disciplinary norms and expectations.
Role of the Corresponding Author
One author is assigned as Corresponding Author and acts on behalf of all co-authors and ensures that questions related to the accuracy or integrity of any part of the work are appropriately addressed.
The Corresponding Author is responsible for the following requirements:
- ensuring that all listed authors have approved the manuscript before submission, including the names and order of authors;
- managing all communication between the Journal and all co-authors, before and after publication;*
- providing transparency on re-use of material and mention any unpublished material (for example manuscripts in press) included in the manuscript in a cover letter to the Editor;
- making sure disclosures, declarations and transparency on data statements from all authors are included in the manuscript as appropriate (see above).
* The requirement of managing all communication between the journal and all co-authors during submission and proofing may be delegated to a Contact or Submitting Author. In this case please make sure the Corresponding Author is clearly indicated in the manuscript.
In absence of specific instructions and in research fields where it is possible to describe discrete efforts, the Publisher recommends authors to include contribution statements in the work that specifies the contribution of every author in order to promote transparency. These contributions should be listed at the separate title page.
Examples of such statement(s) are shown below:
• Free text:
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by [full name], [full name] and [full name]. The first draft of the manuscript was written by [full name] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
• Conceptualization: [full name], …; Methodology: [full name], …; Formal analysis and investigation: [full name], …; Writing - original draft preparation: [full name, …]; Writing - review and editing: [full name], …; Funding acquisition: [full name], …; Resources: [full name], …; Supervision: [full name],….
For review articles where discrete statements are less applicable a statement should be included who had the idea for the article, who performed the literature search and data analysis, and who drafted and/or critically revised the work.
For articles that are based primarily on the student’s dissertation or thesis, it is recommended that the student is usually listed as principal author:
The primary affiliation for each author should be the institution where the majority of their work was done. If an author has subsequently moved, the current address may additionally be stated. Addresses will not be updated or changed after publication of the article.
Changes to authorship
Authors are strongly advised to ensure the correct author group, the Corresponding Author, and the order of authors at submission. Changes of authorship by adding or deleting authors, and/or changes in Corresponding Author, and/or changes in the sequence of authors are not accepted after acceptance of a manuscript.
- Please note that author names will be published exactly as they appear on the accepted submission!
Please make sure that the names of all authors are present and correctly spelled, and that addresses and affiliations are current.
Adding and/or deleting authors at revision stage are generally not permitted, but in some cases it may be warranted. Reasons for these changes in authorship should be explained. Approval of the change during revision is at the discretion of the Editor-in-Chief. Please note that journals may have individual policies on adding and/or deleting authors during revision stage.
Authors are recommended to use their ORCID ID when submitting an article for consideration or acquire an ORCID ID via the submission process.
Deceased or incapacitated authors
For cases in which a co-author dies or is incapacitated during the writing, submission, or peer-review process, and the co-authors feel it is appropriate to include the author, co-authors should obtain approval from a (legal) representative which could be a direct relative.
Authorship issues or disputes
In the case of an authorship dispute during peer review or after acceptance and publication, the Journal will not be in a position to investigate or adjudicate. Authors will be asked to resolve the dispute themselves. If they are unable the Journal reserves the right to withdraw a manuscript from the editorial process or in case of a published paper raise the issue with the authors’ institution(s) and abide by its guidelines.
Authors should treat all communication with the Journal as confidential which includes correspondence with direct representatives from the Journal such as Editors-in-Chief and/or Handling Editors and reviewers’ reports unless explicit consent has been received to share information.
Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals.
Authors should include the following statements (if applicable) in a separate section entitled “Compliance with Ethical Standards” when submitting a paper:
- Disclosure of potential conflicts of interest
- Research involving Human Participants and/or Animals
- Informed consent
Please note that standards could vary slightly per journal dependent on their peer review policies (i.e. single or double blind peer review) as well as per journal subject discipline. Before submitting your article check the instructions following this section carefully.
The corresponding author should be prepared to collect documentation of compliance with ethical standards and send if requested during peer review or after publication.
The Editors reserve the right to reject manuscripts that do not comply with the above-mentioned guidelines. The author will be held responsible for false statements or failure to fulfill the above-mentioned guidelines.
Conflicts of Interest / Competing Interests
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclosure of interests provides a complete and transparent process and helps readers form their own judgments of potential bias. This is not meant to imply that a financial relationship with an organization that sponsored the research or compensation received for consultancy work is inappropriate.
Interests that should be considered and disclosed but are not limited to the following:
Funding: Research grants from funding agencies (please give the research funder and the grant number) and/or research support (including salaries, equipment, supplies, reimbursement for attending symposia, and other expenses) by organizations that may gain or lose financially through publication of this manuscript.
Employment: Recent (while engaged in the research project), present or anticipated employment by any organization that may gain or lose financially through publication of this manuscript. This includes multiple affiliations (if applicable).
Financial interests: Stocks or shares in companies (including holdings of spouse and/or children) that may gain or lose financially through publication of this manuscript; consultation fees or other forms of remuneration from organizations that may gain or lose financially; patents or patent applications whose value may be affected by publication of this manuscript.
It is difficult to specify a threshold at which a financial interest becomes significant, any such figure is necessarily arbitrary, so one possible practical guideline is the following: "Any undeclared financial interest that could embarrass the author were it to become publicly known after the work was published."
Non-financial interests: In addition, authors are requested to disclose interests that go beyond financial interests that could impart bias on the work submitted for publication such as professional interests, personal relationships or personal beliefs (amongst others). Examples include, but are not limited to: position on editorial board, advisory board or board of directors or other type of management relationships; writing and/or consulting for educational purposes; expert witness; mentoring relations; and so forth.
Primary research articles require a disclosure statement. Review articles present an expert synthesis of evidence and may be treated as an authoritative work on a subject. Review articles therefore require a disclosure statement.Other article types such as editorials, book reviews, comments (amongst others) may, dependent on their content, require a disclosure statement. If you are unclear whether your article type requires a disclosure statement, please contact the Editor-in-Chief.
Please note that, in addition to the above requirements, funding information (given that funding is a potential conflict of interest (as mentioned above)) needs to be disclosed upon submission of the manuscript in the peer review system. This information will automatically be added to the Record of CrossMark, however it is not added to the manuscript itself. Under ‘summary of requirements’ (see below) funding information should be included in the ‘Declarations’ section.
Summary of requirements
The above should be summarized in a statement and placed in a ‘Declarations’ section before the reference list under a heading of ‘Funding’ and/or ‘Conflicts of interests’/’Competing interests’. Other declarations include Ethics approval, Consent, Data, Material and/or Code availability and Authors’ contribution statements.
Please see the various examples of wording below and revise/customize the sample statements according to your own needs.
When all authors have the same (or no) conflicts and/or funding it is sufficient to use one blanket statement.
Examples of statements to be used when funding has been received:
- Partial financial support was received from [...]
- The research leading to these results received funding from […] under Grant Agreement No[…].
- This study was funded by […]
- This work was supported by […] (Grant numbers […] and […]
Examples of statements to be used when there is no funding:
- The authors did not receive support from any organization for the submitted work.
- No funding was received to assist with the preparation of this manuscript.
- No funding was received for conducting this study.
- No funds, grants, or other support was received.
Examples of statements to be used when there are interests to declare:
- Financial interests: Author A has received research support from Company A. Author B has received a speaker honorarium from Company Wand owns stock in Company X. Author C is consultant to company Y.
Non-financial interests: Author C is an unpaid member of committee Z.
- Financial interests: The authors declare they have no financial interests.
Non-financial interests: Author A is on the board of directors of Y and receives no compensation as member of the board of directors.
- Financial interests: Author A received a speaking fee from Y for Z. Author B receives a salary from association X. X where s/he is the Executive Director.
Non-financial interests: none.
- Financial interests: Author A and B declare they have no financial interests. Author C has received speaker and consultant honoraria from Company M and Company N. Dr. C has received speaker honorarium and research funding from Company M and Company O. Author D has received travel support from Company O.
Non-financial interests: Author D has served on advisory boards for Company M, Company N and Company O.
Examples of statements to be used when authors have nothing to declare:
- The authors have no relevant financial or non-financial interests to disclose.
- The authors have no conflicts of interest to declare that are relevant to the content of this article.
- All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
- The authors have no financial or proprietary interests in any material discussed in this article.
Authors are responsible for correctness of the statements provided in the manuscript. See also Authorship Principles. The Editor-in-Chief reserves the right to reject submissions that do not meet the guidelines described in this section.
Open Choice allows you to publish open access in more than 1850 Springer Nature journals, making your research more visible and accessible immediately on publication.
Article processing charges (APCs) vary by journal – view the full list
- Increased researcher engagement: Open Choice enables access by anyone with an internet connection, immediately on publication.
- Higher visibility and impact: In Springer hybrid journals, OA articles are accessed 4 times more often on average, and cited 1.7 more times on average*.
- Easy compliance with funder and institutional mandates: Many funders require open access publishing, and some take compliance into account when assessing future grant applications.
It is easy to find funding to support open access – please see our funding and support pages for more information.
*) Within the first three years of publication. Springer Nature hybrid journal OA impact analysis, 2018.
Copyright and license term – CC BY
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under the Creative Commons Attribution License.
Upon acceptance of your article you will receive a link to the special Author Query Application at Springer’s web page where you can sign the Copyright Transfer Statement online and indicate whether you wish to order OpenChoice, paper offprints, or printing of figures in color. Once the Author Query Application has been completed, your article will be processed and you will receive the proofs.
Authors will be asked to transfer copyright of the article to the Phytopathological Society of Japan and Springer Japan (or grant the Publisher exclusive publication and dissemination rights). This will ensure the widest possible protection and dissemination of information under copyright laws.
Offprints can be ordered by the corresponding author.
Online publication of color illustrations is free of charge. For color in the print version, authors will be expected to make a contribution towards the extra costs. Otherwise the figures will be printed in black and white. Please note that, in such cases, it is authors’ responsibility to prepare figures to be illustrative enough to convey the necessary information even after they are converted into black and white.
Authors are informed by e-mail that a temporary URL has been created from which they can obtain their proofs. Proofreading is the responsibility of the authors.
The purpose of the proof is to check for typesetting or conversion errors and the completeness and accuracy of the text, tables and figures. Substantial changes in content, e.g., new results, corrected values, title and authorship, are not allowed without the approval of the Editor.
After online publication, further changes can only be made in the form of an Erratum, which will be hyperlinked to the article.
The article will be published online after receipt of the corrected proofs. This is the official first publication citable with the DOI. After release of the printed version, the paper can also be cited by issue and page numbers.
(Revised on May 24, 2019)